Semi-annual Earnings Preannouncement for 2025
Filed with SSE · · 2 pages · Chinese
Zhejiang Chengyi Pharmaceutical Co. Ltd. on 6ix
Earlier from Zhejiang Chengyi Pharmaceutical
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
- Announcement on Election of Employee Director for the 5th Board of Directors
- Report for Q1 2025
- Announcement on the Acquisition of Drug Registration Certificate for Mercaptopurine Tablets
Later from Zhejiang Chengyi Pharmaceutical
- Announcement on the Acquisition of Drug Registration Certificate for Peramivir Injection
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- Announcement on Retirement and Resignation of Senior Management Member
Follow Zhejiang Chengyi Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Chengyi Pharmaceutical